View Single Post
Old 06-17-2021, 10:41 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,951
Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no b

Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.

More...
News is offline   Reply With Quote